Corrigendum to "EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity" [Journal of Controlled Release, 157 (2012), 287-296]

J Control Release. 2024 Dec 24:S0168-3659(24)00879-4. doi: 10.1016/j.jconrel.2024.12.028. Online ahead of print.
No abstract available

Publication types

  • Published Erratum